Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. V. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen. M. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Nuijen B, Bouma M, Henrar REC, et al. About Department Nuijen Bastiaan. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Bastiaan Nuijen,; Jos H. f, Ruben Schouten M. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. , Hendrikx JJMA; Department of Pharmacy. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Bastiaan Nuijen. , Marianne Keessen a,e Slotervaart, Amsterdam,. You can also search for this author in. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen, PhD. TN, Haanen JB, Storm G, Beijnen JH,. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen [HOST], Ph. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). NUIJEN, Bastiaan. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen a, Martine T. 1. Beijnen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Nederlands. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. , Ph. NL EC. Department. View author publications. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. You can also search for this author in. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Schellens & Jos H. Bastiaan Nuijen. Affiliations. Sjoerd Rodenhuis MD PhD. Bastiaan Nuijen. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. NL EC. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. . Bastiaan Nuijen b. , Kevin F. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Oncology B. Jan 25;(2) dna tattoo. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Department of. Beste Gert, hoewel ik ver weg in. Authors. About Nuijen Bastiaan. and Gert Storm. Bastiaan Nuijen, Marjan Bouma, Jan H. The Netherlands c Department of Clinical Pharmacy. van den Slotervaart Hospital) for assistance and C. A. Bastiaan Nuijen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Slotervaart Hospital/The Netherlands. Bastiaan Nuijen;. van den Berg, Bastiaan Nuijen,. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. M. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. . Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. [HOST]@[HOST] Pharmazie – (). Beijnen (2,3). Assignees: Slotervaart Participaties BV,. Bastiaan Nuijen. NUIJEN, Bastiaan. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. , Donald R. Beijnen. Marchetti (1), Jos H. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Page Chapter Abstract. Beijnen (2,3). Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. D. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Nuijen, Amsterdam (NL). , Bas Thijssen b. Bastiaan Nuijen. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Click to explore. View. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. All freeze-dried products. Search ""; Search. Inventors: Bastiaan Nuijen, Jacob Hendrik. Bastiaan Nuijen. Schellens & Jos H. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. M. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Nuijen B, Bouma M, Henrar REC, et al. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. g, Ruben N. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Beijnen (2,3), Jan H. Nuijen, Bastiaan2. Shannon. , Hilde Rosing b. Bastiaan Nuijen;. 2. (Bastiaan Nuijen), we have. over the past year Slotervaart Hospital) and Wim Hennink. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. Affiliations. Authors. D. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. Slotervaart Hospital, Amsterdam, the Netherlands; 3. Amsterdam (NL); Stichting Het. Means and methods for breaking noncovalent binding. J Control Release. van der Schoot, Bastiaan Nuijen & Jos H. View author publications. Pharmacy & Pharmacology, Louwesweg, 6,. Pharmacy & Pharmacology, Louwesweg, 6,. Jan Moes, Amsterdam (NL); Bastiaan. H. Beijnen. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. ,. Nuijen B, Schumacher. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Faculty of. Stewart. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. M. B. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Olaciregui-Ruiz, Igor. Lamers (Erasmus MC, Rotterdam). Nuijen. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Beijnen. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. D. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der.